Dev Proj 4: Identifying IFN-alpha-Induced Microglial Activation Using...

开发项目 4:使用……识别 IFN-α 诱导的小胶质细胞激活

基本信息

  • 批准号:
    7287021
  • 负责人:
  • 金额:
    $ 3.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

Behavioral co-morbidities including depression, anxiety, irritability, sleep disturbances, fatigue and impaired cognition in patients with cancer are a serious problem. Studies have shown that the majority of cancer patients will experience one or more of these symptoms during treatment, with over a third or more of patients experiencing persisting symptoms after cancer treatment (Ahles et al 2002, Patrick et al 2003, Williams and Dale 2006). Unfortunately, however, more often than not, these symptoms go unrecognized and untreated, and are frequently considered necessary evils of having cancer or having undergone cancer therapy. The lack of appreciation of behavioral comorbidities in cancer patients can come at a high price. Indeed, a number of studies have documented that cancer patients with behavioral problems exhibit poor adherence to treatment, reduced quality of life, and in several instances, increased morbidity and mortality (Dantzer et al 2001, Hopwood and Stephens 2000, Raison and Miller 2003, Stommel et al 2002). Many reasons are given for the paucity of data regarding the nature and treatment of behavioral problems in cancer patients. However, much of the focus to date has been on the psychological and social/occupational impact of carrying a diagnosis of cancer, which makes it "understandable" why someone with cancer might be emotionally distraught. Nevertheless, exciting new developments regarding communication pathways between the immune system and the brain have revolutionized our understanding of how and why patients may develop behavioral problems during cancer and its treatment (Capuron and Miller 2004, Raison et al 2006). There is increasing appreciation that activation of innate immune inflammatory processes and the release of relevant inflammatory cytokines can significantly influence brain function. Indeed, innate immune cytokines can access the brain and have profound effects on neurotransmitter metabolism, neuroendocrine function, synaptic plasticity and behavior. It remains unclear however, whether cytokines released in the periphery influence brain processes through indirect effects on peripheral nervous system pathways or whether peripheral cytokines activate relevant cell types in the brain including microglia, which in turn become an enduring site of inflammation in the central nervous system.
行为共病包括抑郁、焦虑、烦躁、睡眠障碍、疲劳和 癌症患者的认知受损是一个严重的问题。研究表明,大多数 癌症患者在治疗期间会经历一种或多种这些症状,超过三分之一或更多 癌症治疗后出现持续症状的患者(Ahles et al 2002, Patrick et al 2003, 威廉姆斯和戴尔 2006)。然而不幸的是,这些症状往往未被认识到,并且 未经治疗,通常被认为是患有癌症或已经经历过癌症的必然祸害 治疗。对癌症患者的行为合并症缺乏认识可能会付出高昂的代价。 事实上,许多研究表明,有行为问题的癌症患者表现不佳 坚持治疗、生活质量下降,在某些情况下,发病率和死亡率增加 (Dantzer 等人 2001,Hopwood 和 Stephens 2000,Raison 和 Miller 2003,Stommel 等人 2002)。 关于行为的性质和治疗的数据缺乏有很多原因。 癌症患者的问题。然而,迄今为止,大部分关注点都集中在心理和 被诊断患有癌症的社会/职业影响,这使得“可以理解”为什么某人 患有癌症的人可能会情绪激动。尽管如此,令人兴奋的新进展 免疫系统和大脑之间的通讯途径彻底改变了我们对免疫系统的理解 患者在癌症及其治疗期间如何以及为何会出现行为问题(Capuron 和 Miller) 2004 年,Raison 等人,2006 年)。人们越来越认识到先天免疫炎症的激活 过程和相关炎症细胞因子的释放可以显着影响大脑功能。 事实上,先天免疫细胞因子可以进入大脑并对神经递质产生深远的影响 新陈代谢、神经内分泌功能、突触可塑性和行为。但目前尚不清楚,是否 外周释放的细胞因子通过对周围神经的间接影响来影响大脑过程 系统途径或外周细胞因子是否激活大脑中的相关细胞类型,包括小胶质细胞, 这反过来又成为中枢神经系统中持久的炎症部位。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW H MILLER其他文献

ANDREW H MILLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW H MILLER', 18)}}的其他基金

Using Human iPSC Models to Determine the Mechanism of Inflammation-Induced Disruption of Dopamine Neurotransmission
使用人类 iPSC 模型确定炎症引起的多巴胺神经传递中断的机制
  • 批准号:
    10575155
  • 财政年份:
    2022
  • 资助金额:
    $ 3.82万
  • 项目类别:
Using Human iPSC Models to Determine the Mechanism of Inflammation-Induced Disruption of Dopamine Neurotransmission
使用人类 iPSC 模型确定炎症引起的多巴胺神经传递中断的机制
  • 批准号:
    10707196
  • 财政年份:
    2022
  • 资助金额:
    $ 3.82万
  • 项目类别:
Emory Psychiatry Clinical Scientist Training Program (CSTP)
埃默里精神病学临床科学家培训计划 (CSTP)
  • 批准号:
    8894612
  • 财政年份:
    2014
  • 资助金额:
    $ 3.82万
  • 项目类别:
Emory Psychiatry Clinical Scientist Training Program (CSTP)
埃默里精神病学临床科学家培训计划 (CSTP)
  • 批准号:
    8751923
  • 财政年份:
    2014
  • 资助金额:
    $ 3.82万
  • 项目类别:
Inflammation-Induced CNS Glutamate During Breast Cancer Treatment
乳腺癌治疗期间炎症诱导的中枢神经系统谷氨酸
  • 批准号:
    8815732
  • 财政年份:
    2014
  • 资助金额:
    $ 3.82万
  • 项目类别:
Predictors and Targets of Response to Cytokine Antagonism in Depression
抑郁症细胞因子拮抗反应的预测因素和目标
  • 批准号:
    8489793
  • 财政年份:
    2013
  • 资助金额:
    $ 3.82万
  • 项目类别:
Predictors and Targets of Response to Cytokine Antagonism in Depression
抑郁症细胞因子拮抗反应的预测因素和目标
  • 批准号:
    8641432
  • 财政年份:
    2013
  • 资助金额:
    $ 3.82万
  • 项目类别:
Phenotyping Major Depression with Increased Inflammation
炎症加剧的重度抑郁症表型分析
  • 批准号:
    7986778
  • 财政年份:
    2010
  • 资助金额:
    $ 3.82万
  • 项目类别:
Phenotyping Major Depression with Increased Inflammation
炎症加剧的重度抑郁症表型分析
  • 批准号:
    8438483
  • 财政年份:
    2010
  • 资助金额:
    $ 3.82万
  • 项目类别:
Phenotyping Major Depression with Increased Inflammation
炎症加剧的重度抑郁症表型分析
  • 批准号:
    8098152
  • 财政年份:
    2010
  • 资助金额:
    $ 3.82万
  • 项目类别:

相似海外基金

Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.82万
  • 项目类别:
    Fellowship
Clinitouch-360: A digital health platform enabling robust end-to-end care of patients in Primary Care with depression and anxiety
Clinitouch-360:数字健康平台,可为初级保健中的抑郁和焦虑患者提供强大的端到端护理
  • 批准号:
    10098274
  • 财政年份:
    2024
  • 资助金额:
    $ 3.82万
  • 项目类别:
    Collaborative R&D
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
  • 批准号:
    10826673
  • 财政年份:
    2024
  • 资助金额:
    $ 3.82万
  • 项目类别:
Visual analysis system to detect and predict the signs of anxiety in healthcare
用于检测和预测医疗保健中焦虑迹象的视觉分析系统
  • 批准号:
    2902083
  • 财政年份:
    2024
  • 资助金额:
    $ 3.82万
  • 项目类别:
    Studentship
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 3.82万
  • 项目类别:
    Launchpad
Healthy Young Minds: co-producing a nature-based intervention with rural High School students to promote mental well-being and reduce anxiety
健康的年轻心灵:与农村高中生共同开展基于自然的干预措施,以促进心理健康并减少焦虑
  • 批准号:
    MR/Z503599/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.82万
  • 项目类别:
    Research Grant
"Flashforward" imagery and anxiety in young adults: Risk mechanisms and intervention development
年轻人的“闪现”意象和焦虑:风险机制和干预措施的发展
  • 批准号:
    MR/Y009460/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.82万
  • 项目类别:
    Fellowship
How parents manage climate anxiety: coping and hoping for the whole family
父母如何应对气候焦虑:全家人的应对和希望
  • 批准号:
    DP230101928
  • 财政年份:
    2024
  • 资助金额:
    $ 3.82万
  • 项目类别:
    Discovery Projects
An innovative biofeedback enhanced adaptive extended reality (XR) device to reduce perinatal pain and anxiety during and after childbirth
一种创新的生物反馈增强型自适应扩展现实 (XR) 设备,可减少分娩期间和分娩后的围产期疼痛和焦虑
  • 批准号:
    10097862
  • 财政年份:
    2024
  • 资助金额:
    $ 3.82万
  • 项目类别:
    Collaborative R&D
Application name Phase Space - VR hypnotherapy as early intervention for anxiety in students and young people
应用程序名称 Phase Space - VR 催眠疗法作为学生和年轻人焦虑的早期干预
  • 批准号:
    10055011
  • 财政年份:
    2023
  • 资助金额:
    $ 3.82万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了